Categories
Press Release

Pain Management Devices Market by Key Leaders Analysis, Increase CAGR at 9.4% Forecast till 2026

The Global Pain Management Devices Market will benefit from increasing regulatory approvals for neuromodulation devices in recent years. According to a report published by Fortune Business Insights, titled “Pain Management Devices: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 3,922.9 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,046.3 Mn by 2026, exhibiting a CAGR of 9.4%.

Browse Complete Report Details @

https://www.fortunebusinessinsights.com/industry-reports/pain-management-devices-market-101069

Recent technological advancements have opened up a huge pain management devices market growth potential. The report encompasses several factors that have contributed to the growth of the global pain management devices market. Besides this, the report includes a few of the factors that have acted as a barrier to market growth and signifies the market strategies adopted by leading companies, specifically aimed at overcoming these barriers.

Some of the Main Key Players Covered in the Report:

  • Medtronic
  • Boston Scientific Corporation
  • LivaNova
  • Abbott
  • DJO Global LLC
  • SPR Therapeutics
  • Nevro Corp

Get Sample PDF Brochure @

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/pain-management-devices-market-101069

35% Rise in Regulatory Approvals for Pain Management Device Indicates a Huge Potential for Growth in the Foreseeable Future

As the benefits of pain management devices have been unfolded in recent years, there has been an increase in adoption for these devices across the world. Resulting from the increasing demand for pain management devices, there has been a gradual increase in clinical approvals for these devices in recent years.

According to the International Neuromodulation Society, the total number of approvals for neuromodulation devices from the Food and Drug Administration increased by approximately 35% in the past decade. Fortune Business Insights states that the growing usage approvals will favour the growth of the global pain management devices market in the forthcoming years.

Launch of Technologically Advanced Pain Management Devices Likely to Enable Market Growth

Technological advancements in pain management devices have played a huge part in the overall pain management market growth in recent years. Several companies have launched products with better feasibility and high operational efficacy. In January 2019, Boston Scientific announced the launch of an advanced chronic pain management device, which has been identified as one of the very few devices in the market with the ability to combine paresthesia and sub-perception therapy.

The ‘Spectra WaveWriter SCS System’ was launched with the aim of offering a non-drug therapeutic approach for people suffering from chronic pain. The report encompasses product launches, similar to Boston Scientific’s latest device and signifies the importance and impact of such devices on the global pain management devices market.

More Trending Topics from Fortune Business Insights:

Hemostatic Agents Market 2025: Global Size, Key Companies, Trends, Growth and Regional Forecasts Research

Orphan Drugs Market Size, Global Insights, Segmentation and Forecast till 2025 | Fortune Business Insights

Categories
Press Release

Coronary Stents Market Growth Opportunities, Industry Analysis, Top Players by 2025

Growing Regulatory Approvals Will Lead to Substantial Coronary Stents Market Growth

The high prevalence of coronary arterial diseases has opened up a huge coronary stents market potential. Resulting from the high demand for coronary stents, several companies have shifted their focus on developing technologically advanced stents with the aim of serving a wider audience.

Browse Complete Report Details @

https://www.fortunebusinessinsights.com/industry-reports/coronary-stents-market-100065

The coronary stents market trends such as incorporation of micro-sized stents and use of minimally invasive procedures have contributed to the market growth. In recent years, regulatory authorities have eased off on their reluctance to approve coronary stents market products. Abbott’s CE approval for Xience Sierra was a game changer in the coronary stents industry as the device received worldwide allocates for its exceptional functional operations.

The Global Coronary Stents Market potential has widened due to recent technological advancements. According to a report published by Fortune Business Insights, titled “Coronary Stents Market Size, Share and Global Trend by Deployment (Self and Balloon-expandable), Stent Type (Drug Eluting Stent, Bioresorbable Stent, Bare Metal Stent, Covered Stent and Others), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Catheterization Labs) and Geography Forecast till 2025,” the market was valued at US$ 5,244.9 Mn in 2017.

Sample PDF Brochure @

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/coronary-stents-market-100065

Some of the Main Key Players Covered in the Report:

  • Biotronik
  • Cardinal Health
  • Cook Medical
  • C R Bard
  • MicroPort Scientific Corp
  • Terumo Corporation
  • BKK B. Braun Melsungen AG
  • Abbott
  • Boston Scientific
  • Medtronic

Coronary stents possess the ability to enhance severe surgical procedures such as percutaneous coronary intervention (PCI) or angioplasty. The use of coronary stents in regulating the blood supply to the heart has created a huge emphasis on the manufacture of highly efficient products. Coronary stents are inserted into the human arteries to ensure smooth blood supply to the heart. As coronary stents are mostly made up of medical-grade stainless steel, the margin for error is almost zero or minimum.

Key Segmentation:

By Stent Type

  • Drug-Eluting Stent
  • Bioresorbable Stent
  • Bare Metal Stent
  • Covered Stent

By Deployment

  • Self-expandable
  • Balloon-expandable

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Catheterization Labs

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TOC followed by :

  1. North America Coronary Stents Market Analysis, Insights and Forecast, 2014-2025

6.1. Key Findings / Summary

6.2. Market Analysis – By Deployment

6.2.1 Self-Expandable

6.2.2 Balloon Expandable

6.3. Market Analysis – By Stent Type

6.3.1 Drug Eluting Stents (DES)

6.3.2 Bioresorbable Stents

6.3.3 Bare Metal Stents

6.3.4 Covered Stents

6.3.5 Others

6.4. Market Analysis – By End User

6.4.1 Hospitals

6.4.2 Ambulatory Surgical Centers

6.4.3 Specialty Clinics

6.4.4 Catheterization Labs

6.5. Market Analysis – By Country

6.5.1 U.S.

6.5.2 Canada

  1. Europe Coronary Stents Market Analysis, Insights and Forecast, 2014-2025

7.1. Key Findings / Summary

7.2. Market Analysis – By Deployment

7.2.1 Self-Expandable

7.2.2 Balloon Expandable

7.3. Market Analysis – By Stent Type

7.3.1 Drug Eluting Stents (DES)

7.3.2 Bioresorbable Stents

7.3.3 Bare Metal Stents

7.3.4 Covered Stents

7.3.5 Others

7.4. Market Analysis – By End User

7.4.1 Hospitals

7.4.2 Ambulatory Surgical Centers

7.4.3 Specialty Clinics

7.4.4 Catheterization Labs

More Trending Topics from Fortune Business Insights:

Transrectal Ultrasound (TRUS) Market 2019 Global Market Growth, Size, Share, Demand, Trends and Forecasts to 2025

Cardiovascular Stents Market 2019 Industry Size, Trends, Global Growth, Insights and Forecast Research Report 2025

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Categories
Press Release

Sugar Substitutes Market Will Rise a CAGR of 6.3% by the End of 2026

The increasing incidences of lifestyle disorders have led to a rise in the demand of sugar substitutes. According to a report by Fortune Business Insights, titled, “Sugar Substitutes: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 6.35 Bn in 2018. Fortune Business Insights predicts that the market will rise at a CAGR of 6.3%, and reach US$ 10.27 Bn by the end of 2026.

Browse Complete Report Details @

https://www.fortunebusinessinsights.com/industry-reports/sugar-substitutes-market-100261

Asia Pacific Likely to Witness a Rapid Market Growth Throughout the Forecast Period

Geographically, the Global Sugar Substitutes Market is divided into North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. Amongst these, the developed markets of Western Europe and North America are leading the global sugar substitutes market. In 2018, sugar taxes came into force in several markets.

Reduction in the consumption of sugar is likely to occur because the manufacturers are provoked by the global food and beverage industry to not use sugar in beverages, bakery, infant nutrition, and even breakfast cereals. The reduction of sugar has become more like a norm rather than a trend nowadays, as it aligns positively with the purchasing patterns of the consumers.

Request Sample PDF @

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/sugar-substitutes-market-100261

Key segmentation:

By Type

  • Aspartame
  • Acesulfame potassium
  • Saccharine
  • Sucralose
  • Stevia
  • Sugar Alcohols

By Application

  • Food and Beverage
  • Pharmaceuticals
  • Personal Care and Cosmetics

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Some of the Main Key Players Covered in the Report

  • Tate & Lyle
  • Cargill, Incorporated
  • Archer Daniels Midland Company
  • Ingredion Incorporated
  • Roquette Frères
  • The Nutra Sweet Company
  • Ajinomoto Co., Inc.
  • JK Sucralose Inc.
  • DowDuPont
  • Pure Circle Limited

Segments of Table-Top and Beverages are Likely to Lead the Market

In terms of application, the global sugar substitutes market is segmented into beverage, table-top, beverages, bakery and confectionery, other processed food, pharmaceuticals, and personal care and cosmetics. Amongst these, table-top and beverages are projected to lead the global sugar substitutes market during the forecast period.

On the other hand, beverages remain dominant in the global sugar substitutes market and the segment will continue to maintain its position throughout the forecast period. This is because consumers are demanding low-calories or sugar-free formulations. At the same time, bakery and confectionary segment has started adopting sugar-reduction to cater to the needs of the health-conscious consumers.

This is anticipated to occur because masses across the globe have recently started to look for ways to maintain a healthy lifestyle. Sugar tops their list when it comes to health and wellness needs. As a result, consumer opinions and perspectives towards table sugar and beverages have changed rapidly. A number of multinational companies have started offering sugar-free and sugar-reduced products.

Natural Sweeteners are Anticipated to Grow Faster than Artificial Sweeteners

Synthetic sugar alternatives, namely, aspartame, acesulfame potassium, and saccharine have been dominating the global sugar substitutes market due to a rise in their demand from developed markets and also due to vigorous consumption patterns. But, natural sweeteners such as monk fruit and stevia are projected to become more popular than the artificial ones.

Roquette Frères, a French-based company, has already started working on producing natural sweeteners. It has launched Nutriose, a soluble plant-based fiber for food and nutrition which acts as a reliable sugar substitute.

More Trending Topics from Fortune Business Insights:

Revenue US$ 722.0 Mn, Ophthalmic Lasers Market| Industry Size, Share and Global Trend

Next-Generation Sequencing Market Is Expected to cross US$ 31,411.3 Mn by 2026, at a CAGR Of 22.2%

Categories
Press Release

Biostimulants Market Business Opportunities, Key Leaders Analysis, Growth, Future Trends Forecast to 2026

The Global Biostimulants Market is likely to gain impetus from a rise in the demand for high-value crops. According to a report published by Fortune Business Insights, titled, “Biostimulants: Global Market Analysis, Insights and Forecast, 2019-2026,” the global market is projected to reach US$ 5.68 Bn by the end of 2026. It will exhibit a CAGR of 12.4% during the forecast period (2019-2026). The global market was valued at US$ 2.24 Bn in 2018.

Browse Complete Report Details @

https://www.fortunebusinessinsights.com/industry-reports/biostimulants-market-100414

The report further states that the governments of numerous countries have begun focusing on the usage of natural or biological origin agricultural inputs in crop production for increased yield and better quality. It is one of the major factors that is anticipated to boost the global biostimulants market growth during the forecast period. Moreover, renowned enterprises operating in the global market are focusing on launching technologically advanced and novel products. This is another factor that will increase the sales of biostimulants in the coming years.

Some of the Main Key Players Covered in the Report

  • Syngenta
  • BASF
  • BioAg Pty Ltd
  • Monsanto Company
  • Arysta Lifescience
  • Koppert Biological Systems
  • Valagro Pacific
  • Isagro

Get Sample PDF [email protected]

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/biostimulants-market-100414

Key Segmentation:

By Type

  • Seaweed Extracts
  • Humic Substances
  • Vitamins & Amino Acids
  • Microbial Amendments

By Application Method

  • Foliar Spray
  • Soil Treatment
  • Seed Treatment

By Formulation

  • Powder/Dry
  • Liquid

By Crop Type

  • Cereals
  • Oilseeds
  • Fruits & vegetables
  • Turf & ornamentals

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Increasing Launch of Awareness Programs to Promote the Adoption of Sustainable Farming Products and Practices to Favor Growth in Europe

The global biostimulants market is geographically divided into the Middle East and Africa, Europe, Asia Pacific, Latin America, and North America. Amongst these regions, Europe and North America have acquired the largest global biostimulants market share generating approximately 50% revenue altogether.

The market in Europe is anticipated to grow rapidly during the forecast period owing to the rising number of governmental awareness programs that are encouraging the populace in adopting sustainable farming methods, tools, and substances. Several biostimulant promoting councils are also present in this region. One of them is the European Biostimulant Industry Council (EBIC), which is considered to be the most prominent when it comes to promoting the usage of biostimulants among the European farmers.

Futureco Bioscience, Italpollina, and Other Key Market Players Launch Innovative Products to Gain Competitive Edge

Futureco Bioscience, an agrobiotechnology company, involved in the research, development, and worldwide commercialization of products for the protection of crops, based in Spain, announced in that it has launched ‘Radisan’ May 2019. It is a new biostimulant that can be used in the development of roots. It can also improve the structure of a plant and strengthens its general state. Radisan can be applied to a variety of crops during their vegetative growth as it has several benefits.

Italpollina, a provider of biotechnological and certified solutions for modern agriculture, based in Italy, launched Tandem, an innovative biostimulant product in February 2019. It consists of a strain of beneficial microorganism infused with LRPP. The product will aid in promoting the development of roots. Tandem also contains vegetal peptides that improve plant resistance to harsh climatic conditions, namely, excess heat, cold, drought, or even lack of nutrients in the soil.

More Trending Topics from Fortune Business Insights:

North America Fats and Oils Market to Rise Steadily at 4.5% CAGR by 2026

Diabetes Drugs Market 2019 Global Market Growth, Size, Share, Demand, Trends and Forecasts to 2026

 

Categories
Press Release

Global Guillain-Barre Syndrome Treatment Market to Gain Traction; FDA Clears CSL’s Immunoglobulin, Privigen

With the Guillain-Barre syndrome becoming increasingly prevalent, the global Guillain-Barre syndrome market expansion is poised to progress steadily in the forecast period. Fortune Business Insights shares valuable market analysis in its report, titled “Guillain-Barre Syndrome Treatment Market Size, Share and Global Trend By Type (Acute Inflammatory Demyelinating Polyradiculoneuropathy, Miller Fisher Syndrome, Acute Motor Axonal Neuropathy, Acute Motor-Sensory Axonal Neuropathy), By Treatment (Plasmapheresis, Immunoglobulin therapy, Others), By Route of Administration (Oral, Parental), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) and Geography Forecast till 2026”.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/guillain-barre-syndrome-treatment-market-101002

In the report is also contained a comprehensive evaluation of the factors that will influence the market and the probable market trends that will emerge.

Some of the major companies that are present in the Global Guillain- Barre Syndrome Market are

  • Grifols S.A.
  • CSL Behring LLC
  • Shire plc,
  • Octapharma AG,
  • Nihon Pharmaceutical Co., Ltd.
  • Akari Therapeutics, PLC
  • China Biologic Products Holdings, Inc.
  • Biotest AG, and others

Guillain-Barre syndrome is an autoimmune disease that is rare and occurs when the body’s immune system begins attacking the healthy nerve cells in the peripheral nervous system. This results in numbness, weakness, and eventual paralysis. Researchers have been unable to find a definite cause; but, many experts are of the opinion that the disease is triggered by infection to the lungs or the gastric region. The most common type of Guillain-Barre syndrome is the Acute Inflammatory Demyelinating Polyradiculoneuropathy, which affects the myelin.

Staggering Rate of Increase to Propel Market Growth

The global Guillain-Barre syndrome treatment market is up for robust growth owing to the astonishing increase in the prevalence of the disease. According to a study published jointly by the US National Library of Medicine, the National Institutes of Health, and PLOS One Journal, approximately 100,000 new cases of the Guillain-Barre syndrome are registered annually. While the numbers are disturbing, they signal good news for the global Guillain-Barre syndrome treatment market, which will see considerable expansion as a result in the coming decade.

Get Sample PDF Brochure at https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/guillain-barre-syndrome-treatment-market-101002

Possible Links with Dengue and Zika Virus May Aid the Market

A study published by PLOS One revealed that the Guillain-Barre syndrome is associated with the Zika and Chikungunya virus. In some cases, the onset of the disease was preceded by a dengue infection in the patient. The Centre for Disease Control and Prevention believes that an improper and insufficient response by the immune system to such infections triggers the syndrome. With frequent epidemics of dengue, zika, and chikungunya, especially in tropical countries, the global Guillain-Barre syndrome treatment market is poised to gain substantially during the forecast period.

Low Awareness Levels to Hinder Market Growth

Awareness levels regarding Guillain-Barre syndrome are low across the globe, particularly in low and middle-income countries. Moreover, the medication to treat the disease is expensive and vague, while insurance policies do not sufficiently cover the treatment procedures. All these factors are expected to play a restraining role on the global Guillain-Barre syndrome treatment market in the forecast period.

Regulatory Approvals for Innovative Products to Boost Market Investment

Spain-based Grifols S.A. has been developing Flebogamma, an immunoglobulin to treat various autoimmune diseases, including Guillain-Barre syndrome and Kawasaki Disease. The medicine recently got approval by the European Medicines Agency to launch it commercially in the European market. Such regulatory approvals bode well for the global Guillain-Barre syndrome treatment market as other key players will be encouraged to invest in research and develop new products.

According to Fortune Business Insights, the important players in the global Guillain-Barre syndrome treatment market include Akari Therapeutics, PLC, Biotest AG, Octapharma AG, CSL Behring LLC, China Biologic Products Holdings, Inc., Grifols S.A., among others.

Speak To Analyst at https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/guillain-barre-syndrome-treatment-market-101002

North America to Hold Dominant Market Share; Asia-Pacific to Boast an Impressive CAGR

Presence of major market players, increasing investment in research, and a well-entrenched healthcare infrastructure will put North America in a dominant position in the global Guillain-Barre syndrome treatment market. Increasing incidence of bacterial infections such as diarrhoea is also expected to boost the market in North America. In terms of CAGR, Asia-Pacific is anticipated to register a high growth rate in the global Guillain-Barre syndrome treatment market till 2026. This is owing to growing awareness of the disease in developing countries such as India and China, a large patient pool, rising epidemic rates of viral infections.

KEY QUESTIONS ANSWERED:

What is the market size and growth rate of the global and regional market by various segments?

What is the market size and growth rate of the market for selective countries?

Which region or sub-segment is expected to drive the market in the forecast period?

What Factors are estimated to drive and restrain the market growth?

What are the key technological and market trends shaping the market?

What are the key opportunities in the market?

What are the key companies operating in the market?

Which company accounted for the highest market share?

Why Choose Fortune Business Insights?

More Trending Topics from Fortune Business Insights:

Essential Oils Market Key Factor Analysis with Top Players: Biolandes SAS, Now Foods, International Flavors & Fragrances Inc., and more

Cosmetic Dentistry Market 2019 Global Size, Growth Insight, Share, Trends, Industry Key Players, Regional Forecast To 2026

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Categories
Press Release

Global C-Arms Market to Grow with Increasing Prevalence of Chronic Diseases

As chronic diseases become more widespread, the global C-arms market is expected to grow considerably during the forecast period. Fortune Business Insights shares valuable market analysis in its report, titled “C-arms Market Size, Share and Global Trend by Size (Mini C-arms, Compact C-arms, Full-size C-arms, Others), By Application (Cardiology, Urology, Neurology, Orthopaedics, Others), By Type (Fixed, Mobile), By Technology (Image Intensifiers, Flat Panel Detectors), By End User (Hospitals, Specialty Clinics, Diagnostics & Imaging Centers, Others), and Geography Forecast till 2026”. The report also incorporates a comprehensive evaluation of emerging market trends and factors that will impact the market.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/c-arms-market-100993

Some of the major companies that are present in the Global C-Arms Market are;

C-Arms Market
C-Arms Market
  • General Electric Company
  • Siemens AG
  • Koninklijke Philips N.V.
  • Agfa-Gevaert Group
  • Fujifilm Holdings Corporation
  • Shimadzu Corporation
  • Hitachi, Ltd.
  • Hologic Inc
  • Carestream Health
  • Varian Medical Systems, Inc.
  • Imaging Dynamics Company Ltd., and others.

C-arms are fluoroscopic machines that intensify the resolution of the images taken using X-rays. They work on the same premise as X-ray machines and are essentially advanced medical imaging devices. They are named so because of the C-shaped present in the machine that connects the detector with the X-ray source. The technology is non-invasive and is widely being employed in different medical procedures.

Multiple Benefits of C-arms to Boost the Market

The global C-arms market is set to witness substantial growth on account of the growing awareness about the multiple benefits of using C-arms machines. For example, C-arms technology is non-invasive in nature, making it a safe and reliable option before and after surgery. These systems enable physicians to get real-time images of patients’ internal structure and perform procedures more efficiently and accurately. A more precise diagnosis is also made possible by these machines. Moreover, C-arms devices are portable and flexible and hence can be easily carried and installed in different locations. These factors are expected to work in favour of the global C-arms market during the forecast period.

Get Sample PDF Brochure at https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/c-arms-market-100993

Wide Applicability of C-arms to Aid Market Expansion

As a result of their non-invasive character, C-arms systems are finding wide applicability across various medical procedures. For instance, C-arms technology is becoming popular in imaging and diagnosing kidney drainage in high resolution. The technique is also being employed in cardiovascular surgeries, valve replacement procedures, gastroenterology, anaesthetics, neuro stimulation, among others. The increasing popularity of the technology across the medical field is anticipated to provide a forward thrust to the global C-arms market till 2026.

Lack of Access to Well-Functioning Medical Equipment in Developing Nations to Hinder Market Growth

According to the WHO, 50 to 80% of medical equipment in developing nations is not working. Moreover, accessing advanced medical technology, such as C-arms machines, is difficult for low and middle-income countries. Countries that can afford them find it hard to maintain them owing to high maintenance costs and lack of trained professionals. These factors are likely to restrain the global C-arms market growth as developing nations have large patient pools.

Speak To Analyst at https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/c-arms-market-100993

Increasing Investment in Innovation to Fuel Market Competition; Regulatory Approvals Send Positive Signals

Key players in the global C-arms market are increasingly focussing their investment energies on research and innovation so as to develop new products and diversify their product range. For example, Ziehm Imaging developed the Vision RFD that combines the flexibility and mobility of C-arm with fixed room imaging capabilities. Moreover, regulatory approvals are expected to encourage firms to double down their efforts in innovation and make the global C-arms market more dynamic. For example, Siemens Healthineers received FDA clearance in late 2018 for its innovative mobile C-arms system, Cios Spin, that is capable of provide advanced 3D images.

Fortune Business Insights covers some of the major market participants. These include Fujifilm Holdings Corporation, General Electric Company, Imaging Dynamics Company Ltd., Siemens AG, Koninklijke Philips N.V., Carestream Health, Shimadzu Corporation, and others.

High Adoption Rates to Spur the Market in North America

Higher adoption rates along with robust healthcare infrastructure, presence of major players, increasing geriatric population, and growing incidence of chronic diseases will keep North America in a commanding position in the global C-arms market during the forecast period. Asia-Pacific is to closely follow on account of growing preference for minimally invasive procedures and greater access to advanced imaging technologies.

KEY QUESTIONS ANSWERED:

  • What is the market size and growth rate of the global and regional market by various segments?
  • What is the market size and growth rate of the market for selective countries?
  • Which region or sub-segment is expected to drive the market in the forecast period?
  • What Factors are estimated to drive and restrain the market growth?
  • What are the key technological and market trends shaping the market?
  • What are the key opportunities in the market?
  • What are the key companies operating in the market?
  • Which company accounted for the highest market share?
  • Why Choose Fortune Business Insights?

View Related Report at

What’s driving the Sedation in ICU Setting Market Growth? Prominent Players: Aspen Holdings, Mylan N.V., Astra Zeneca and more

Probiotics in Animal Feed Market 2019 Global Industry Share, Size, Global Industry Analysis, Key Growth Drivers Trends, Segments, Emerging Technologies, Opportunity and Forecast 2019 to 2026

Rehabilitation Robots Market 2019 Movements by Trend Analysis, Growth Status, Revenue Expectation to 2026

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Categories
Press Release

Ophthalmic Lasers Market Business Opportunity, In-Depth Qualitative Insights, Share by 2026

In addition to this, the global market was worth US$ 479.0 Mn in 2018 and is anticipated to reach US$ 722.0 Mn by 20226. The increasing incidence of ocular diseases, such as glaucoma, age-related macular degeneration, and refractive errors, is driving the ophthalmic laser market. As the drugs for treating ocular diseases is less, the demand for ophthalmic laser devices has come into existence.

Browse Complete Report Details @

https://www.fortunebusinessinsights.com/industry-reports/ophthalmic-lasers-market-100952

The Global Ophthalmic Lasers Market reflects an impressive growth owing to the growing prevalence of refractive errors across the world. According to a report, published by Fortune Business Insights, titled, “Ophthalmic Lasers Market: Global Market Analysis, Insights and Forecast, 2019-2026” the global market is expected to register a CAGR of 5.3% between 2019 and 2026.

Some of the Main Key Players Covered in the Report

  • IRIDEX Corporation
  • Lumenis
  • NIDEK CO., LTD.
  • Carl Ziess Meditec AG
  • Ellex Medical Lasers Ltd.
  • TOPCON CORPORATION
  • NoIR Laser Company, LLC
  • Lumibird

Excimer Lasers Gain an Upper Hand Over Other Laser Types

In 2018, the excimer lasers among other types of ophthalmic lasers covered 39.2% of the global market. These lasers are used for procedures such as refractive error correction. Recent technological advancements are expected to boost the segment growth during the forecast period. The demand for ophthalmic laser systems is likely to increase in hospitals, ophthalmic laser centers, among others.

Get Sample PDF [email protected]

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/ophthalmic-lasers-market-100952

Key Segmentation:

By Type

  • Excimer Lasers
  • Femtosecond Lasers
  • Nd Yag Lasers
  • Diode Lasers

By Technology

  • Photodisruption
  • Selective Laser Trabeculoplasty
  • Photocoagulation

By Application

  • Cataract Treatment
  • Glaucoma Treatment
  • Refractive Errors Treatment

By End User

  • Ophthalmic Laser Centers
  • Hospitals

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Carl Zeiss’s VisuMax Receives FDA Approval to Bring Innovation in Laser Eye Surgery

The global ophthalmic laser market is semi-consolidated with the presence of three leading players. These players include Lumenis, TOPCON CORPORATION, and Ellex Medical Lasers, Ltd. covered the maximum share in the year 2018. These players are well-recognized and have a robust distribution network in the medical laser segment. Such factors are responsible for the dominance of these players. Several companies are focusing on to launch new products in order to strengthen their distribution channel.

For instance, Novartis AG (Alcon) announced FDA approval for LenSx in March 2018. The product has two indications, one for creating tunnels allowing placement of corneal rings, whereas the other is to create corneal pockets for effective placement of presbyopia-correcting inlays. Another company called Carl Zeiss Meditec AG announced FDA approval for VisuMax femtosecond laser system in September 2016. This system is used to perform small-incision lenticule extraction for refractive correction.

The report profiles some of the leading players functioning in the global ophthalmic laser market. These include IRIDEX Corporation, Ellex Medical Lasers Ltd., NIDEK CO., LTD., Lumibird, TOPCON CORPORATION, NoIR Laser Company, LLC, and Lumenis.

More Trending Topics from Fortune Business Insights:

Retinal Disease Therapeutics Market: 2019 Worldwide Opportunities, Market Share, Key Players and Competitive Landscape

Wound Care Devices Market Share Growing Rapidly with Recent Trends, Regional Analysis Forecast To 2025